We are pleased to share quarterly progress updates on the following items:
Food and Drug Administration Path to an IDE Submittal
New Regional Clinics
Our Twitter post from June 26, 2023.
Just a brief update – last week as scheduled we conducted an IsoPet® Therapy on this #horse. We look forward to sharing results in an expanded update soon.
— IsoPet® Solutions (@IsoPet_RadioGel) June 26, 2023
Thank you.#horse #animalcancer #savinglives $RDGL https://t.co/owpGMihmPG
IsoPet® is a next generation treatment option, providing a same day therapy, using relatively low activity to deliver a high therapeutic dose that stays at the injection site with no contamination in the urine or feces.
Veterinarian Dr. Michael Myhre treated the clinic’s first equine patient for a sarcoma on its tail.
Marketing
Therapy Support System Equipment
The pig/vial containers are transparent acrylic. They are designed to ship the IsoPet® solution, and stay in the container. All shown with nylon lid threaded shoulder screw. The nylon screw is removed, and the patented hydrogel withdrawn by a syringe; once again serving as a radiation shield.
Advisory Boards
We reconstituted and strengthened our Veterinary Medicine and Medical advisory boards. They continue to provide valuable senior guidance.
Financial
The 2nd Quarter 10-Q was been filed on schedule.
Thank you for your continued support.
Mike Korenko, Sc. D
CEO & President Vivos Inc.
CONTACT:
Vivos Inc.
Michael K. Korenko, Sc.D.
President & CEO